BioStem Technologies (OTC: BSEM)

Biotechnology Research • Pompano Beach, Florida, United States • 51-100 Employees

Company overview

Headquarters	2836 Center Port Circle, Pompano Beach, FL 33064, US
Phone number	+19543808342
Websites	biostemtechnologies.com biostemtech.com
SIC	283
Keywords	Biotechnology, Stem Cell Therapy, Regenerative Medicine
Founded	2014
Employees	51-100
Socials

Key Contacts at BioStem Technologies (OTC: BSEM)

Jason Matuszewski

Chief Executive Officer

Tom Dugan

Chairman Of The Board Of Directors

Adam Holdsworth

Director Of Investor Relations

Alex Ruggieri

Director Of Business Operations

David Grodin

Director Of Financial Planning & Analysis

Gwen Tucker

Human Resources Director

Taylor Sabol

Director Of Quality

BioStem Technologies (OTC: BSEM) Email Formats

BioStem Technologies (OTC: BSEM) uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@biostemtech.com), used 95.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@biostemtech.com	95.8%
{first name}	john@biostemtech.com	4.2%

About BioStem Technologies (OTC: BSEM)

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

BioStem Technologies (OTC: BSEM) revenue & valuation

Annual revenue	$131,500,000
Revenue per employee	$2,435,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$420,600,000
Total funding	$2,000,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

BioStem Technologies (OTC: BSEM) has 35 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore BioStem Technologies (OTC: BSEM)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-03	14	$2,000,000

Funding Insights

$2,000,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

BioStem Technologies (OTC: BSEM) Tech Stack

Discover the technologies and tools that power BioStem Technologies (OTC: BSEM)'s digital infrastructure, from frameworks to analytics platforms.

Usercentrics

Cookie compliance

Cloudflare Bot Management

Security

Gravity Forms

Form builders

Kadence WP Kadence

WordPress themes

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Salesforce Marketing Cloud Account Engagement

Marketing automation

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

BioStem Technologies (OTC: BSEM) is located in Pompano Beach, Florida, US.

You can reach BioStem Technologies (OTC: BSEM) at +19543808342.

BioStem Technologies (OTC: BSEM) was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

BioStem Technologies (OTC: BSEM) has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

BioStem Technologies (OTC: BSEM) has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.